The European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) have released international guidelines on the role of PET/CT in patients with invasive ductal carcinoma breast cancer. The guidelines highlight the usefulness of F-18 FDG-PET/CT in breast cancer management, including initial staging, assessing treatment response, and search for recurrence. The document has been endorsed by several organizations and should be viewed as a dynamic document that can be modified according to local legislation and regulations. The authors emphasize the extensive evidence supporting the utility of F-18 FDG-PET/CT in breast cancer management.
Fri, 17 May 2024 07:03:39 GMT | AuntMinnie